Vascular influences of calcium supplementation and vitamin D-induced hypercalcemia in NaCl-hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 3, 2003, Pages 319-328

  Kähönen, Mika ^a,b   Näppi, Satu ^b   Jolma, Pasi ^a   Hutri Kähönen, Nina ^a,b   Tolvanen, Jari Petteri ^a   Saha, Heikki ^b   Koivisto, Pasi ^b   Krogerus, Leena ^c   Kalliovalkama, Jarkko ^a   Pörsti, Ilkka ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Calcium supplementation; Endothelium; Hypercalcemia; Hypertension; Smooth muscle; Vitamin D

Indexed keywords

ACETYLCHOLINE; ALFACALCIDOL; CALCIUM; CROMAKALIM; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; POTASSIUM CHLORIDE; SODIUM CHLORIDE; TETRYLAMMONIUM; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY MUSCLE; ARTERY TONE; ARTICLE; BODY WEIGHT; CALCIFICATION; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; DRUG MECHANISM; HYPERCALCEMIA; HYPERPOLARIZATION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION; WEIGHT GAIN;

ANIMALS; APOPTOSIS; BLOOD PRESSURE; CALCIUM, DIETARY; HYPERCALCEMIA; HYPERTENSION; MALE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITROPRUSSIDE; RATS; RATS, INBRED WKY; SODIUM CHLORIDE; VASODILATION; VITAMIN D;

EID: 0042839702     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200309000-00002     Document Type: Article

References (37)

1. Cutler JA, Brittain E. Calcium and blood pressure: an epidemiologic perspective. Am J Hypertens. 1990;3:137S-146S.
2. Hatton DC, McCarron DA. Dietary calcium and blood pressure in experimental models of hypertension. Hypertension. 1994;23:513-530.
3. Sacks FM, Brown LE, Appel L, et al. Combinations of potassium, calcium, and magnesium supplements in hypertension. Hypertension. 1995; 26:950-956.
4. Arvola P, Ruskoaho H, Pörsti I. Effects of high calcium diet on arterial smooth muscle function and electrolyte balance in mineralocorticoid-salt hypertensive rats. Br J Pharmacol. 1993;108:948-958.
5. Mäkynen H, Kähönen M, Arvola P, et al. Endothelial function in deoxycorticosterone-NaCl hypertension: effect of calcium supplementation. Circulation. 1996;93:1000-1008.
6. 1-adrenergic mechanism. Am J Physiol. 1993;264: F234-F238.
7. 2+ receptor and blood pressure regulation: a hypothesis. Am J Hypertens. 1998;11:1117-1123.
8. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? I-Analysis of observational data among populations. BMJ. 1991;302:811-815.
9. Brown AJ, Dusso A, Slatopolsky E. Vitamin D. Am J Physiol. 1999;277: F157-F175.
10. 2+ and force generation in resistance arteries. Am J Physiol. 1996;270: H230-H237.
11. 3 modifies growth and contractile function of vascular smooth muscle of spontaneously hypertensive rats. Am J Physiol. 1989;2:553-556.
12. 3. Am J Hypertens. 1993;6:388-396.
13. 3-induced alterations in vascular reactivity in the SHR. Am J Med Sci. 1994;307: S154-S158.
14. Borges AC, Feres T, Vianna LM, et al. Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension. 1999;34:897-901.
15. + channels in mesenteric arteries from spontaneously hypertensive rats by prolonged treatment with cholecalciferol. Br J Pharmacol. 1999;127:772-778.
16. 3 on blood pressure and resistance artery contractility in the spontaneously hypertensive rat. Am J Hypertens. 1993;6:944-950.
17. 3 enhances resistance artery contractile properties. Hypertension. 1990;16: 523-531.
18. 3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation. 1998;98:1302-1306.
19. Fleckenstein A, Frey M, Zorn J, et al. The role of calcium in the pathogenesis of experimental atherosclerosis. Trends Pharmacol Sci. 1987;8: 496-501.
20. Fleckenstein-Grün G, Fleckenstein A. Calcium: a neglected key factor in arteriosclerosis. The pathogenetic role of arterial calcium overload and its prevention by calcium antagonists. Ann Med. 1991;23:589-599.
21. Shioi A, Mori K, Jono S, et al. Mechanism of atherosclerotic calcification. Z Kardiol. 2000;89(suppl 2):II/75-II/79.
22. Arvola P, Pörsti I, Vuorinen P, et al. Contractions induced by potassium-free solution and potassium relaxation in vascular smooth muscle of hypertensive and normotensive rats. Br J Pharmacol. 1992;106:157-165.
23. +]: A functional approach to separating EDHF- and EDNO-related mechanism in perfused rat mesenteric arterial bed. J Cardiovasc Pharmacol. 1993;21:423-429.
24. Kitazono T, Faraci FM, Taguchi H, et al. Role of potassium channels in cerebral blood vessels. Stroke. 1995;26:1713-1723.
25. Bukoski RD, Ishibashi K, Bian K. Vascular actions of the calcium regulating hormones. Semin Nephrol. 1995;15:536-549.
26. 3 increases serum and tissue accumulation of aluminum in rats. J Lab Clin Med. 1986;108:96-102.
27. Okada M, Noguchi S, Hasegava Y, et al. Effect of pamidronate in a rat hypercalcaemia model induced by cholecalciferol. Arzneim Forch. 1992; 42:543-546.
28. Busse R, Fleming I. The endothelial organ. Curr Opin Cardiol. 1993;8: 719-727.
29. Fujii K, Tominaga M, Ohmori S, et al. Decreased endothelium-dependent hyperpolarization to acetylcholine in smooth muscle of the mesenteric artery of spontaneously hypertensive rats. Circ Res. 1992;70:660-669.
30. Jameson M, Dai F, Lüscher T, et al. Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension. Hypertension. 1993;21:280-288.
31. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. Circulation. 1995;92:3337-3349.
32. Van de Voorde J, Vanheel B, Leusen I. Endothelium-dependent relaxation and hyperpolarization in aorta from control and renal hypertensive rats. Circ Res. 1992;70:1-8.
33. Bolotina VM, Najibi S, Palacino JJ, et al. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 1994;368:850-853.
34. Randall MD, McCulloch AI. The involvement of ATP-sensitive potassium channels in β-adrenoceptor-mediated vasorelaxation in the rat isolated mesenteric arterial bed. Br J Pharmacol. 1995;115:607-612.
35. + channels in smooth muscle cells from basilar artery of guinea pig. Pflügers Arch Eur J Physiol. 1995;430:983-993.
36. 3 and vitamin D analogs. Curr Pharm Des. 2000;6: 717-732.
37. Shanahan CM, Cary NRB, Salisbury JR, et al. Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis. Evidence for smooth muscle cell-mediated vascular calcification. Circulation. 1999;100:2168-2176.